Shattuck Labs, Inc. (STTK)
Last updated: 2026-10-20 10:01:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Shattuck Labs, Inc. (STTK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.74, with a market capitalization of $543.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.72 to $8.33. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$543.97M | |
$5.38 | |
$60.52 | |
$0.69 | |
$5.37 | |
85.00 | |
1.14M | |
-- | |
$8.33 | |
$1.72 | |
-- | |
-- |
Shattuck Labs, Inc. (STTK) Pre-Market Stock Price
Shattuck Labs, Inc. (STTK) is trading at $5.74 in pre-market trading as of 2026-10-20 09:03:00, up 6.85% ($0.37) from the previous close of $5.37
Pre-market trading shows how investors are pricing STTK before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Shattuck Labs, Inc. (STTK) 7-Day Stock Price Change
Over the past seven days, Shattuck Labs, Inc. (STTK) moved from $5.97 to $5.74, representing a decline of 3.89% ($0.23).
The stock traded between $5.19 and $6.21 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 1.03 million shares, down versus the previous seven-day period, indicating lower trading activity.
STTK 52-Week Price Position
Position in Range: 60.8%
STTK is currently trading at $5.74, placing it 60.8% of the way from its 52-week low of $1.72 to its 52-week high of $8.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Shattuck Labs, Inc. (STTK)?
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Shattuck Labs, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 40 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Shattuck Labs, Inc. (STTK) Stock on MEXC
Eligible investors can buy real shares of Shattuck Labs, Inc. (STTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Shattuck Labs, Inc. (STTK) stock price today?
2.Is STTK stock going up or down today?
3.What is STTK pre-market price?
4.What is STTK after-hours price?
5.Is STTK stock trading now?
6.Where does STTK sit relative to its 52-week high and low?
7.What sector is Shattuck Labs, Inc. in?
8.What is Shattuck Labs, Inc.'s market capitalization and where is it listed?
9.How is STTK valued in terms of P/E ratio and EPS?
10.Does Shattuck Labs, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
STTK Stock Calculator
Estimate the value between STTK shares and USD.
STTK Shares to USD
1.00 STTK shares = 5.738 USD
Calculations are estimates based on the latest available price and are for reference only.


